This topic contains a solution. Click here to go to the answer

Author Question: Review the following routes of drug administration, and select the one that is most commonly used ... (Read 93 times)

cabate

  • Hero Member
  • *****
  • Posts: 537
Review the following routes of drug administration, and select the one that is most commonly used for pediatric therapy.
 
  a. Oral
  b. Rectal
  c. Topical
  d. Intravenous

Question 2

Which of the following types of antibodies (immunoglobulins IGs) protect most full-term newborns against infectious agents?
 
  a. IgA
  b. IgE
  c. IgG
  d. IgM



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

todom5090

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

ANS: D
The intravenous (IV) route is commonly used in pediatric therapy. For some drugs, it is the only effective route. When a drug is administered intravenously, the effect is almost instantaneous, and further control is limited. Most drugs intended for IV administration require a specified minimum dilution and/or rate of infusion.

Answer to Question 2

ANS: C
Passively acquired maternal IgG antibodies protect most full-term newborns against a variety of infectious agents until the immature immune system mechanisms begin to function between the ages of 2 and 3 months.



cabate

  • Hero Member
  • *****
  • Posts: 537
Both answers were spot on, thank you once again




 

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library